Literature DB >> 30653227

Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials.

Jessica K Roydhouse1, Mallorie H Fiero2, Paul G Kluetz3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30653227     DOI： 10.1001/jamaoncol.2018.6205

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  12 in total

1.  The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology.

Authors:  Julie A Schneider; Yutao Gong; Kirsten B Goldberg; Paul G Kluetz; Marc R Theoret; Laleh Amiri-Kordestani; Julia A Beaver; Lola Fashoyin-Aje; Nicole J Gormley; Adnan A Jaigirdar; Steven J Lemery; Pallavi S Mishra-Kalyani; Gregory H Reaman; Donna R Rivera; Wendy S Rubinstein; Harpreet Singh; Rajeshwari Sridhara; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

2.  Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal Toxicity.

Authors:  Daniel Lin; Shalini Moningi; Joseph Abi Jaoude; Ben S Singh; Irina M Cazacu; Ramez Kouzy; Graciela M Nogueras Gonzalez; Phonthep Angsuwatcharakon; Joseph M Herman; Manoop S Bhutani; Cullen M Taniguchi
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

3.  Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials.

Authors:  Fabio Efficace; David Cella; Neil K Aaronson; Melanie Calvert; Francesco Cottone; Massimo Di Maio; Francesco Perrone; Francesco Sparano; Eva-Maria Gamper; Marco Vignetti; Johannes M Giesinger
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816

4.  Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication.

Authors:  Nathan Anderson; Andrea G Gillman; Ajay D Wasan
Journal:  J Pain Res       Date:  2020-05-06       Impact factor: 3.133

5.  Personalized quantification of facial normality: a machine learning approach.

Authors:  Osman Boyaci; Erchin Serpedin; Mitchell A Stotland
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

6.  Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma.

Authors:  Pier Luigi Zinzani; Radhakrishnan Ramchandren; Armando Santoro; Ewa Paszkiewicz-Kozik; Robin Gasiorowski; Nathalie A Johnson; Jose S R de Oliveira; Valeria Buccheri; Guilherme Fleury Perini; Michael Dickinson; Andrew McDonald; Muhit Özcan; Naohiro Sekiguchi; Ying Zhu; Monika Raut; Todd L Saretsky; Akash Nahar; John Kuruvilla
Journal:  Blood Adv       Date:  2022-01-25

7.  Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective.

Authors:  Meena N Murugappan; Bellinda L King-Kallimanis; Gregory H Reaman; Vishal Bhatnagar; Erica G Horodniceanu; Najat Bouchkouj; Paul G Kluetz
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

8.  Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.

Authors:  Benzi M Kluger; Janis Miyasaki; Maya Katz; Nicholas Galifianakis; Kirk Hall; Steven Pantilat; Ryan Khan; Cari Friedman; Wendy Cernik; Yuika Goto; Judith Long; Diane Fairclough; Stefan Sillau; Jean S Kutner
Journal:  JAMA Neurol       Date:  2020-05-01       Impact factor: 18.302

Review 9.  Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials.

Authors:  Guillaume Mouillet; Fabio Efficace; Antoine Thiery-Vuillemin; Emilie Charton; Mieke Van Hemelrijck; Francesco Sparano; Amélie Anota
Journal:  Cancer Med       Date:  2020-08-26       Impact factor: 4.452

10.  Prospective Randomized Phase II Study of Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionated Radiotherapy (CFRT) for Chinese Patients with Early-Stage Localized Prostate Cancer.

Authors:  Darren M C Poon; Daisy Lam; Kenneth C W Wong; Cheuk-Man Chu; Michael Cheung; Frankie Mo; Joyce Suen; Chi-Fai Ng; Anthony T C Chan
Journal:  Curr Oncol       Date:  2021-12-22       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.